Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check21 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA Locations section has been added, listing Ontario and the Toronto, Canada site (St. Michael's Hospital). The previous Ontario Locations entry and the HHS Vulnerability Disclosure link have been removed in this revision.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision to v3.3.1.SummaryDifference0.1%

- Check85 days agoChange DetectedDeleted the government funding lapse notice from the page, removing guidance about potential data updates and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.